Progress on 2023 DSCSA Interoperability

Pharmaceutical Industry on Steady March Toward Readiness

To capture "a snapshot of implementation progress" for meeting the requirements of the Drug Supply Chain Security Act (DSCSA), AmerisourceBergen Corporation, Cardinal Health and McKesson Pharmaceutical, in collaboration with GS1 Healthcare US®, continue to assess the barcode readability on packages and homogenous cases in their facilities.*

Read the latest report to see the double-digit gains in proper barcoding and how this information is important in meeting full interoperability in 2023.

“Throughout the five years of conducting this focused study with GS1 US, we have witnessed drug serialized standards move from essentially uncommon and unfamiliar among our manufacturer trading partners, to almost ubiquitous in our most recent study.”
- Sean Murphy Manufacturer Operations at AmerisourceBergen Corporation

*For information about the act, see the 2013 Drug Supply Chain Security Act

Disclaimer: GS1 US is the local GS1 Member Organization that supports implementation of the GS1 System in the United States. GS1 US employees are not representatives or agents of the U.S. FDA, and the content herein has not been reviewed, approved, or authorized by the U.S. FDA.